ScholarIQanswers from OpenAlex & ORCID
Axel Hoos
ResearcherPublications, citations & collaboration network
Axel Hoos is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Axel Hoos have?
ScholarIQindexed works
Axel Hoos has 318 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Axel Hoos have?
ScholarIQcitation count
Axel Hoos has 42,548 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Axel Hoos?
ScholarIQh-index
Axel Hoos has an h-index of 68 in OpenAlex.
What is the i10-index of Axel Hoos?
ScholarIQi10-index
Axel Hoos has an i10-index of 134 in OpenAlex.
What is the ORCID of Axel Hoos?
ScholarIQorcid
The ORCID for Axel Hoos is on the source record.
What is the OpenAlex record for Axel Hoos?
ScholarIQopenalex
The OpenAlex for Axel Hoos is on the source record.
What are the most-cited papers on Axel Hoos?
ScholarIQmost cited works
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert, L. Thomas, Igor Bondarenko, Steven O’Day, Jeffrey S. Weber, Claus Garbe, Célèste Lebbé, Jean‐François Baurain, Alessandro Testori, Jean‐Jacques Grob, Neville Davidson, Jon Richards, Michele Maio, Axel Hauschild, Wilson H. Miller, Pere Gascón, Michal Lotem, Kaan Harmankaya, Ramy Ibrahim, Stephen Francis, Tai‐Tsang Chen, Rachel Humphrey, Axel Hoos, Jedd D. Wolchok
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
Sagar Lonial, Hans C. Lee, Ashraf Badros, Suzanne Trudel, Ajay K. Nooka, Ajai Chari, Al‐Ola Abdallah, Natalie S. Callander, Nikoletta Lendvai, Douglas W. Sborov, Attaya Suvannasankha, Katja Weisel, Lionel Karlin, Edward N. Libby, Bertrand Arnulf, Thierry Façon, Cyrille Hulin, K. Martin Kortüm, Paula Rodríguez‐Otero, Saad Z. Usmani, Parameswaran Hari, Rachid Baz, Hang Quach, Philippe Moreau, Peter M. Voorhees, Ira Gupta, Axel Hoos, Eric Zhi, January Baron, Trisha Piontek, Eric Lewis, Roxanne C. Jewell, Elisha J. Dettman, Rakesh Popat, Simona Degli Esposti, Joanna Opalinska, Paul G. Richardson, Adam D. Cohen
Defining the critical hurdles in cancer immunotherapy
Bernard A. Fox, Dolores J. Schendel, Lisa H. Butterfield, Steinar Aamdal, James P. Allison, Paolo A. Ascierto, Michael B. Atkins, Jiřina Bartůňková, Lothar Bergmann, Neil L. Berinstein, Cristina C Bonorino, Ernest C. Borden, Jonathan L. Bramson, Cedrik M. Britten, Xuetao Cao, William E. Carson, Alfred E. Chang, Dainius Characiejus, Aniruddha Choudhury, George Coukos, Tanja D. de Gruijl, Robert O. Dillman, Harry Dolstra, Glenn Dranoff, Lindy G. Durrant, James H. Finke, Jérôme Galon, Jared Gollob, Cécile Gouttefangeas, Fabio Grizzi, Michele Guida, Leif Håkansson, Kristen Hege, Ronald B. Herberman, F. Stephen Hodi, Axel Hoos, Christoph Huber, Patrick Hwu, Kohzoh Imai, Elizabeth M. Jaffee, Sylvia Janetzki, Carl H. June, Paweł Kaliński, Howard L. Kaufman, Koji Kawakami, Yutaka Kawakami, Ulrich Keilholtz, Samir N. Khleif, Rolf Kiessling, Beatrix Kotlán, Guido Kroemer, Réjean Lapointe, Hyam I. Levitsky, Michael T. Lotze, Cristina Maccalli, Michele Maio, Jens‐Peter Marschner, Michael J. Mastrangelo, Giuseppe Masucci, Ignacio Melero, C.J.M. Melief, William J. Murphy, Brad H. Nelson, Andrea Nicolini, Michael I. Nishimura, Kunle Odunsi, Pamela S. Ohashi, Jill O’Donnell-Tormey, Lloyd J. Old, Christian H. Ottensmeier, Michael Papamichail, Giorgio Parmiani, Graham Pawelec, Enrico Proietti, Shukui Qin, Robert C. Rees, Antoni Ribas, Ruggero Ridolfi, Gerd Ritter, Licia Rivoltini, Pedro Romero, Mohamed L. Salem, Rik J. Scheper, Barbara Seliger, Padmanee Sharma, Hiroshi Shiku, Harpreet Singh‐Jasuja, Wenru Song, Per thor Straten, Hideaki Tahara, Zhigang Tian, Sjoerd H. van der Burg, Paul von Hoegen, Ena Wang, Marij J.P. Welters, H. Winter, Tara Withington, Jedd D. Wolchok, Weihua Xiao, Laurence Zitvogel